Video Experimental Relacionado
Updated: Jan 7, 2026

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
Adopción en el mundo real de combinaciones fuera de etiqueta para la resistencia a la terapia dirigida en el cáncer
Justin Battaglini1, Maha AlDoughaim2,3,4, Katie Li5
1Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, 830 Harrison Ave, Moakley Suite 3200, Boston, MA, 02118, USA.
No abstract available in PubMed .
Más Videos Relacionados
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Videos de Conceptos Relacionados
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...